Search

Your search keyword '"Mahé, I"' showing total 674 results

Search Constraints

Start Over You searched for: Author "Mahé, I" Remove constraint Author: "Mahé, I"
674 results on '"Mahé, I"'

Search Results

1. Venous thromboembolism characteristics and outcomes among RIETE patients tested and untested for inherited thrombophilia

2. Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism

3. Traduction et republication de : « Traitement de la maladie thromboembolique veineuse associée au cancer chez les patients en soins palliatifs »

4. Traduction et republication de : « Prise en charge de la maladie thromboembolique veineuse associée au cancer chez les populations vulnérables »

5. Traduction et republication de : « Thrombose veineuse profonde du membre supérieur associée à un cathéter veineux central chez les patients cancéreux : diagnostic et prise en charge thérapeutique »

6. Traduction et republication de : « Maladie thromboembolique veineuse récidivante chez les patients cancéreux anticoagulés : diagnostic et traitement »

9. Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry

11. A prognostic score to identify women at increased risk for abnormal uterine bleeding during anticoagulation for venous thromboembolism

12. COVID-19–associated venous thromboembolism: risk of recurrence and major bleeding

14. Venous thromboembolism characteristics, treatment and outcomes in young adults: findings from the Registro Informatizado de Enfermedad TromboEmbólica registry

15. Towards optimal use of antithrombotic therapy of people with cancer at the end of life: A research protocol for the development and implementation of the SERENITY shared decision support tool

16. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

18. Traduction et republication de : « Maladie thromboembolique veineuse récidivante chez les patients cancéreux anticoagulés : diagnostic et traitement »

19. Traduction et republication de : « Prise en charge de la maladie thromboembolique veineuse associée au cancer chez les populations vulnérables »

20. Timing and characteristics of venous thromboembolism after noncancer surgery

22. Recommandations de bonne pratique pour la prise en charge de la maladie veineuse thromboembolique chez l’adulte – Version longue

25. Comparative clinical prognosis of massive and non‐massive pulmonary embolism: A registry‐based cohort study

26. Symptomatic subsegmental versus more central pulmonary embolism: Clinical outcomes during anticoagulation

27. First three months of anticoagulation for venous thromboembolism in non-cancer patients: LMWH VS. VKAs. Findings from the RIETE registry

30. Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembólica Registry

31. Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry

32. Republication de : Recommandations de bonne pratique pour la prise en charge de la maladie veineuse thromboembolique chez l’adulte. Version courte

33. Recommandations de bonne pratique pour la prise en charge de la maladie veineuse thromboembolique chez l’adulte. Version courte

34. Venous thromboembolism characteristics and outcomes among RIETE patients tested and untested for inherited thrombophilia

35. A prognostic score to identify women at increased risk for abnormal uterine bleeding during anticoagulation for venous thromboembolism

36. Venous thromboembolism characteristics, treatment and outcomes in young adults: findings from the Registro Informatizado de Enfermedad TromboEmbólica registry

38. Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism

40. Real-life experience of quality of life, treatment satisfaction, and adherence in patients receiving oral anticoagulants for atrial fibrillation

42. Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism

44. Treatment of Right Heart Thrombi Associated with Acute Pulmonary Embolism

45. Development of a Risk Prediction Score for Occult Cancer in Patients With VTE

46. The Clinical Course of Venous Thromboembolism May Differ According to Cancer Site

47. Analysis of noncatheter-associated upper extremity deep venous thrombosis from the RIETE registry

48. Assessment of quality of life, satisfaction with anticoagulation therapy, and adherence to treatment in patients receiving long-course vitamin K antagonists or direct oral anticoagulants for venous thromboembolism

49. The risk of recurrent venous thromboembolism after discontinuation of anticoagulant therapy in patients with cancer-associated thrombosis:a systematic review and meta-analysis

50. Towards optimal use of antithrombotic therapy of people with cancer at the end of life:A research protocol for the development and implementation of the SERENITY shared decision support tool

Catalog

Books, media, physical & digital resources